Cargando…
Development of an evidence-based regimen of prednisolone to treat giant cell arteritis – the Norwich regimen
We have reviewed the literature to form a bespoke regimen for daily oral prednisolone (DP) in GCA. Initial DP in clinical trials is 40–60 mg daily, but relapse rates are 67–92%. Cumulative prednisolone (CP) of 3.2 and 3.9 g (at 6 months) resulted in a relapse rate of 83 and 67%, respectively; and 3...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649920/ https://www.ncbi.nlm.nih.gov/pubmed/31431989 http://dx.doi.org/10.1093/rap/rkz001 |